Tilray Inc (NASDAQ:TLRY - Get Free Report) was up 3.8% during trading on Thursday . The stock traded as high as $1.79 and last traded at $1.79. Approximately 11,610,644 shares were traded during trading, a decline of 60% from the average daily volume of 29,361,824 shares. The stock had previously closed at $1.72.
Wall Street Analysts Forecast Growth
Several research analysts recently weighed in on the stock. CIBC lowered their target price on shares of Tilray from $2.25 to $2.00 and set a "neutral" rating on the stock in a research note on Wednesday, April 10th. Canaccord Genuity Group lowered their price objective on shares of Tilray from $4.25 to $4.00 and set a "buy" rating on the stock in a research report on Wednesday, April 10th. Finally, Alliance Global Partners lifted their price objective on shares of Tilray from $2.25 to $2.75 and gave the stock a "neutral" rating in a report on Friday, April 5th.
View Our Latest Stock Report on TLRY
Tilray Price Performance
The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.18 and a current ratio of 1.92. The stock's 50 day moving average price is $1.96 and its 200-day moving average price is $1.96. The company has a market cap of $1.28 billion, a PE ratio of -3.91 and a beta of 2.36.
Institutional Investors Weigh In On Tilray
Institutional investors have recently bought and sold shares of the stock. Clear Street Markets LLC purchased a new stake in Tilray in the 3rd quarter worth approximately $25,000. Macquarie Group Ltd. grew its holdings in Tilray by 188.8% in the second quarter. Macquarie Group Ltd. now owns 8,540 shares of the company's stock worth $27,000 after purchasing an additional 5,583 shares during the period. Oppenheimer & Co. Inc. bought a new position in shares of Tilray during the fourth quarter valued at approximately $27,000. Captrust Financial Advisors lifted its holdings in shares of Tilray by 47.9% during the second quarter. Captrust Financial Advisors now owns 17,821 shares of the company's stock valued at $28,000 after purchasing an additional 5,768 shares during the last quarter. Finally, Lake Street Financial LLC bought a new stake in shares of Tilray in the 3rd quarter worth approximately $28,000. 9.35% of the stock is currently owned by hedge funds and other institutional investors.
Tilray Company Profile
(
Get Free Report)
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Further Reading
Before you consider Tilray, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tilray wasn't on the list.
While Tilray currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.
Get This Free Report
